We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > MG

News List

Harbour BioMed's Batoclimab (HBM9161) Receives China CDE Breakthrough Therapy Designation for Treatment of Adult Patients with Myasthenia Gravis prnasia
January 28, 2021
Harbour BioMed (HBM), announced today that China Center for Drug Evaluation (CDE) has granted Breakthrough Therapy designation to Batoclimab (HBM 9161), a fully human anti-FcRn monoclonal antibody (mAb), for the treatment of adult patients with ...
MG America Appoints Processing Division Sales Manager contractpharma
June 12, 2019
Wortham brings more than 15 years of experience managing sales of machinery, vision inspection and serialization solutions.
Ra Pharma files $100M round as Soliris rival clears phase 2 trial fiercebiotech
December 27, 2018
Armed with a phase 2 win for its lead drug zilucoplan in rare disease myasthenia gravis (MG), Ra Pharma has pressed the button on a public funding round that it hopes could raise up to $115 million......